Trials / Completed
CompletedNCT03845764
Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy
Interobserver Agreement Between Pulmonologist, Pathologist and Molecular Pathologist in the Assessment of Tumor Burden on ROSE Slides Obtained With Endoscopic Procedures From Pulmonary Nodules and Intrathoracic Lymphadenopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 164 (actual)
- Sponsor
- Maggiore Bellaria Hospital, Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The study is aimed at verifying if a pulmonologist can reliably assess the tumor burden for the extractive molecular analysis in ROSE samples obtained with endoscopic sampling procedures from intrathoracic lymphadenopathy and pulmonary nodules.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Rapid on-site evaluation | Specimens obtained with endoscopic sampling procedures are stained with a rapid method (i.e., Diff Qui) and submitted to on-site cytologic review |
Timeline
- Start date
- 2019-02-18
- Primary completion
- 2019-06-30
- Completion
- 2019-07-30
- First posted
- 2019-02-19
- Last updated
- 2019-08-15
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT03845764. Inclusion in this directory is not an endorsement.